AMERICAN SHARED HOSPITAL SERVICES Additional Paid in Capital, Common Stock
AMERICAN SHARED HOSPITAL SERVICES (AMS) had Additional Paid in Capital, Common Stock of $9.21 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-13
- 2026-06-30: Additional Paid in Capital, Common Stock $9.21M.
- 2026-03-31: Additional Paid in Capital, Common Stock $9.11M.
- 2025-12-31: Additional Paid in Capital, Common Stock $9.01M.
- 2025-09-30: Additional Paid in Capital, Common Stock $8.91M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $9.21M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $9.11M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $9.01M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $8.91M 10-Q/A · filed 2026-01-16 |
| 2025-06-30 | $8.81M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $8.69M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $8.61M 10-K · filed 2026-03-31 |
| 2024-09-30 | $8.52M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $8.43M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $8.33M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $8.23M 10-K · filed 2025-04-04 |
| 2023-09-30 | $8.13M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $8.04M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $7.94M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $7.84M 10-K · filed 2024-04-01 |
| 2022-09-30 | $7.68M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $7.60M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $7.53M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $7.44M 10-K · filed 2023-03-31 |
| 2021-09-30 | $7.34M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $7.23M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $7.13M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $7.02M 10-K · filed 2022-03-30 |
| 2020-09-30 | $6.91M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $6.83M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $6.78M 10-Q/A · filed 2020-06-11 |
| 2019-12-31 | $6.72M 10-K · filed 2021-04-06 |
| 2019-09-30 | $6.67M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $6.60M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $6.55M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $6.50M 10-K · filed 2020-04-03 |
| 2018-09-30 | $6.44M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $6.38M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $6.33M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $6.27M 10-K · filed 2019-03-29 |
| 2017-09-30 | $6.11M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $6.05M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $6.00M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $5.95M 10-K · filed 2018-03-28 |
| 2016-09-30 | $5.89M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $5.85M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $5.79M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $5.73M 10-K · filed 2017-03-27 |
| 2015-09-30 | $5.66M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $5.60M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $5.54M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $5.51M 10-K · filed 2016-03-30 |
| 2014-09-30 | $5.04M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $5.04M 10-Q · filed 2014-08-15 |
| 2014-03-31 | $5.02M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $4.99M 10-K · filed 2015-04-01 |
| 2013-09-30 | $4.97M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $4.96M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $4.94M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $4.90M 10-K · filed 2014-03-31 |
| 2012-09-30 | $4.89M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $4.89M 10-Q/A · filed 2012-09-07 |
| 2012-03-31 | $4.86M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $4.83M 10-K · filed 2013-03-29 |
| 2011-09-30 | $4.80M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $4.78M 10-Q/A · filed 2011-10-24 |
| 2010-12-31 | $4.70M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |